Drug intelligence / Profile preview

ampicillin + tobramycin

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Ampicillin + tobramycin is an antibiotic combination that demonstrates synergistic effects against various bacterial infections. This combination pairs ampicillin, a beta-lactam antibiotic, with tobramycin, an aminoglycoside antibiotic. Studies have shown that this combination exhibits synergistic activity against aminoglycoside-resistant group B streptococci and certain gram-negative bacteria, including Escherichia coli. The combination achieves rapid bacterial killing at concentrations where each antibiotic alone would be insufficient to be bactericidal. The synergistic effect is particularly notable against Pseudomonas, Klebsiella, E. coli, and both Staphylococcus aureus and albus.

02

Targets

H69 (23S ribosomal RNA helix 69)PBP (Penicillin-binding protein family)30S A-site (Bacterial ribosomal 30S A-site)

Beyond the preview

Go deeper on ampicillin + tobramycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ampicillin + tobramycin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call